Inventor · disambiguated record
Amirreza Faridmoayer
Also filed as: FARIDMOAYER AMIRREZA
13 granted patents·15 pending applications·9 citations·filing 2007–2024
85Inventor score
Files withGLAXOSMITHKLINE BIOLOGICALS SA14LIMMATECH BIOLOGICS AG7GLYCOERA AG2ISIS INNOVATION2FARIDMOAYER AMIRREZA1
Top patents by PatentIndex Score
28 records- 0184US11286283B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Mar 29, 2022·2 cites·20 claims
- 0281US12442019B2Process for the manipulation of nucleic acidsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2024·Granted Oct 14, 2025·0 cites·13 claims
- 0378US11959092B2Process for the manipulation of nucleic acidsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Apr 16, 2024·1 cites·4 claims
- 0476US11819544B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Nov 21, 2023·1 cites·15 claims
- 0576US10307474B2Modified host cells and hybrid oligosaccharides for use in bioconjugate productionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2015·Granted Jun 4, 2019·2 cites·10 claims
- 0670US11236136B2Methods of producing glycosylated proteinsLIMMATECH BIOLOGICS AG·Filed 2016·Granted Feb 1, 2022·1 cites·13 claims
- 0770US2024287568A1Engineered and Fully-Functional Customized GlycoproteinsLIMMATECH BIOLOGICS AG·Filed 2024·Application pending·0 cites
- 0867US2024100140A1Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2023·Application pending·0 cites
- 0966US12128096B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Oct 29, 2024·0 cites·13 claims
- 1065US9238830B2Methods and systems for O-glycosylating proteinsFELDMAN MARIO·Filed 2007·Granted Jan 19, 2016·2 cites·64 claims
- 1164US2022242920A1Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 1261US2022025419A1N-glycosylation of peptides and proteinsISIS INNOVATION·Filed 2021·Application pending·0 cites
- 1359US11285200B2Modified host cells and hybrid oligosaccharides for use in bioconjugate productionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Granted Mar 29, 2022·0 cites·17 claims
- 1459US2022242919A1Methods of producing glycosylated proteinsLIMMATECH BIOLOGICS AG·Filed 2021·Application pending·0 cites
- 1557US11654190B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted May 23, 2023·0 cites·5 claims
- 1657US10973901B2Production of recombinant vaccine in E. coli by enzymatic conjugationGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Apr 13, 2021·0 cites·16 claims
- 1756US11913051B2Engineered and fully-functional customized glycoproteinsLIMMATECH BIOLOGICS AG·Filed 2018·Granted Feb 27, 2024·0 cites·49 claims
- 1856US2025281626A1Mannose 3 glycan-mediated protein degradationGLYCOERA AG·Filed 2022·Application pending·0 cites
- 1956US2025282886A1Glycan-mediated protein degradationGLYCOERA AG·Filed 2022·Application pending·0 cites
- 2053US11376314B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Jul 5, 2022·0 cites·16 claims
- 2151US2024067714A1Fab sialylation of antibodiesLIMMATECH BIOLOGICS AG·Filed 2021·Application pending·0 cites
- 2250US2016257983A1N-glycosylation of peptides and proteinsISIS INNOVATION·Filed 2014·Application pending·0 cites
- 2350US2023287327A1Glycoengineering using leishmania cellsLIMMATECH BIOLOGICS AG·Filed 2021·Application pending·0 cites
- 2449US2015273043A1Production of recombinant vaccine in e.coli by enzymatic conjugationGLYCOVAXYN AG·Filed 2013·Application pending·0 cites
- 2547US2022298205A1Methods for protein purificationGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Application pending·0 cites
- 2642US2023048847A1Engineered leishmania cellsLIMMATECH BIOLOGICS AG·Filed 2021·Application pending·0 cites
- 2741US2014336366A1Bioconjugate vaccines made in prokaryotic cellsFARIDMOAYER AMIRREZA·Filed 2012·Application pending·0 cites
- 2834US2019248841A1Immunogenic CompositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Amirreza Faridmoayer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →